Vasudeva Bhat

Adjunct Research Professor

Western University

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Tissue Engineering Tissue Engineering professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vasudeva Bhat is an Adjunct Research Professor at Western University, Canada. His research areas encompass cancer biology, particularly focusing on breast cancer and its treatment modalities. Recent publications include investigations into the role of Artemis in cancer, the FGF2-DACH1 axis in breast cancer stemness, and the potential of PLK4 as a target to enhance radiosensitivity in triple-negative breast cancer. He also explores the impact of the AKT pathway in drug resistance and the clinical applications of radiotherapy in cancer treatment.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Michael Lock

Western University

CANADA

View details

Eugene Wong

Western University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vasudeva Bhat

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Artemis and its role in cancer

Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis

Centrosomes and associated proteins in pathogenesis and treatment of breast cancer

PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer

Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines

Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications

Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study

Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples.

Collaborators (2)

Michael Lock

Eugene Wong

Make your next move.